Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury

被引:14
|
作者
Chen, Fanghong [1 ]
Zhang, Guanjian [1 ]
Cao, Yanli [1 ]
Payne, Ryan [1 ]
See, William A. [1 ]
机构
[1] Med Coll Wisconsin, Dept Urol, Milwaukee, WI 53226 USA
来源
JOURNAL OF UROLOGY | 2007年 / 178卷 / 05期
关键词
bladder; bladder neoplasms; Mycobacterium bovis; apoptosis;
D O I
10.1016/j.juro.2007.06.040
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: By inducing cell cycle arrest at the G1/S transition bacillus Calmette-Guerin has been shown to have a direct antiproliferative effect on urothelial carcinoma cell lines. In other systems cell cycle arrest has been shown to confer a relative state of apoptotic resistance. We assessed the effect of bacillus Calmette-Guerin on the susceptibility of urothelial carcinoma cells to apoptotic stimuli. Materials and Methods: The human UC cell lines T24 and 253J (American Type Cell Culture, Rockville, Maryland) were used to evaluate the effect of bacillus Calmette-Guerin or antibody mediated alpha 5 beta 1cross-linking on apoptosis and apoptotic sensitivity. Following treatment baseline apoptosis and the response to the apoptotic inducing agent camptothecin was evaluated using assays for caspase 3 activation and DNA fragmentation. Pharmacological blockade of signaling pathways known to be activated in response to bacillus Calmette-Guerin/alpha 5 beta 1 cross-linking was used to assess the role of these pathways in the bacillus Calmette-Guerin apoptotic response. A final series of experiments used the MTT assay to study the impact of bacillus Calmette-Guerin pretreatment on the cytotoxicity of the antineoplastic agent mitomycin C. Results: Treatment with bacillus Calmette-Guerin failed to induce apoptosis, as measured by caspase 3 activation or DNA laddering. Bacillus Calmette-Guerin pretreatment significantly inhibited the induction of apoptosis in response to camptothecin. These effects were reproduced by antibody mediated cross-linking of alpha 5 beta 1 integrin. Pharmacological inhibition of nuclear factor kappa B and/or AP1 signaling pathways reversed the anti-apoptotic effect of bacillus Calmette-Guerin. Mitomycin C cytotoxicity was significantly decreased by bacillus Calmette-Guerin pretreatment. Conclusions: Bacillus Calmette-Guerin exerts a direct anti-apoptotic effect on human urothelial carcinoma cell lines. The ability of antibody mediated cross-linking to reproduce the effect and the ability of signal transduction inhibitors to block it are consistent with a mechanism involving integrin mediated signaling. Apoptotic resistance represents a therapeutic target for modulating the response to bacillus Calmette-Guerin and it may have clinical implications in the sequencing of intravesical therapies.
引用
收藏
页码:2166 / 2170
页数:5
相关论文
共 50 条
  • [21] HMGB1 Release by Urothelial Carcinoma Cells is Required for the In Vivo Antitumor Response to Bacillus Calmette-Guerin
    Zhang, Guangjian
    Chen, Fanghong
    Cao, Yanli
    Johnson, Bryon
    See, William A.
    JOURNAL OF UROLOGY, 2013, 189 (04): : 1541 - 1546
  • [22] BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    SCHELLHAMMER, PF
    LADAGA, LE
    FILLION, MB
    JOURNAL OF UROLOGY, 1986, 135 (02): : 261 - 264
  • [23] Expression of Toll-Like Receptors (TLRs) in Urothelial Carcinoma and Response to Bacillus Calmette-Guerin (BCG) Therapy
    D'Alfonso, T. M.
    Robinson, B. D.
    Kaufman, E. C.
    Scherr, D. S.
    LABORATORY INVESTIGATION, 2010, 90 : 186A - 186A
  • [24] Expression of Toll-Like Receptors (TLRs) in Urothelial Carcinoma and Response to Bacillus Calmette-Guerin (BCG) Therapy
    Alfonso, T. M. D.
    Robinson, B. D.
    Kaufman, E. C.
    Scherr, D. S.
    MODERN PATHOLOGY, 2010, 23 : 186A - 186A
  • [25] Differential gene expression in different bladder carcinoma cell lines treated with Bacillus Calmette-Guerin (BCG)
    Schwarzer, K.
    Lehmann, M.
    Hanemann, V.
    Straube, E.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 296 : 170 - 171
  • [26] The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder
    Kim, JC
    Steinberg, GD
    JOURNAL OF UROLOGY, 2001, 165 (03): : 745 - 756
  • [27] Bacillus Calmette-Guerin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy
    Yamashita, Ryo
    Matsuzaki, Masato
    Niwakawa, Masashi
    Ito, Ichiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (03) : 333 - 334
  • [28] Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette-Guerin therapy for urothelial carcinoma in situ
    Plonowska-Hirschfeld, Karolina A.
    Fung, Monica
    Glastonbury, Christine
    Ha, Patrick K.
    CLINICAL CASE REPORTS, 2021, 9 (06):
  • [29] Urine fluorescence in situ hybridization analysis during Bacillus Calmette-Guerin treatments in urothelial carcinoma
    Karnes, RJ
    Halling, KC
    Lieber, MM
    Zincke, H
    Blute, ML
    JOURNAL OF UROLOGY, 2003, 169 (04): : 259 - 259
  • [30] DURABLE RESPONSE OF A CARCINOMA INSITU OF THE RENAL PELVIS TO TOPICAL BACILLUS CALMETTE-GUERIN
    HERR, HW
    SOLOWAY, MS
    OLSSON, CA
    JOURNAL OF UROLOGY, 1985, 134 (03): : 531 - 532